← Back to Influence Map
Entity DossierOrganization
ALEXION PHARMACEUTICALS, INC.
MA · US
Biopharmaceutical Company
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$1,360,000
Connections
5
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$2.3MMMMMedicare/Medicaid
$1.5MLBRLabor/Employment
$360KLobbying Firms Retained
FEROX STRATEGIES$840K
TODD STRATEGY GROUP$760K
FORBES-TATE$700K
Bills Referenced in Lobbying Filings
H.R. 5376
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | FORBES-TATE | Hired FORBES-TATE to lobby on Pharmaceuticals | Source |
| Lobbied on | Inflation Reduction Act - Drug Pricing Provisions (H.R.5376) | LDA filing: lobbied on IRA Drug Pricing Provisions, period 1st Quarter (Jan 1 - Mar 31), reported amount $50,000 | Source |
| Lobbied on | Inflation Reduction Act - Energy Provisions (H.R.5376) | LDA filing: lobbied on Inflation Reduction Act - Energy, period 1st Quarter (Jan 1 - Mar 31), reported amount $50,000 | Source |
| Retained | TODD STRATEGY GROUP | Hired TODD STRATEGY GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | FEROX STRATEGIES | Hired FEROX STRATEGIES to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |